| Financial Year |
March 31 2023 |
| Monetary Funds |
643,910,247.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
113,645,894.32 |
| Accounts Receivable |
1,107,614,500.66 |
| Advances to Suppliers |
107,330,800.33 |
| Other Receivables |
46,669,949.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
730,742,659.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
111,960,726.49 |
| Other Current Assets |
46,186,808.85 |
| Total Current Assets |
3,267,657,047.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,000,000.00 |
| Long-term Equity Investment |
213,969,452.35 |
| Investment Properties |
9,509,478.24 |
| Fixed Assetes |
594,817,080.29 |
| Under-construction Projects |
61,893,333.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
428,336,974.12 |
| R&D expenses |
2,940,745.72 |
| Goodwill |
468,855,208.93 |
| Long-Term Deferred and Prepaid Expenses |
13,500,328.58 |
| Deferred Income Tax Assets |
50,926,197.47 |
| Other Non-Current Assets |
560,261,921.43 |
| Sub-Total of Non-Current Assets |
2,726,338,193.11 |
| Total Assets |
5,993,995,240.46 |
| Short-Term Loans |
178,245,008.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
459,500,695.12 |
| Accounts Payable |
442,645,773.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,630,756.58 |
| Taxes Payable |
28,336,730.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,698,849.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,037,969.95 |
| Other Current Liabilities |
55,140,990.59 |
| Sub-Total of Current Liabilities |
1,654,536,781.63 |
| Long-term Loans |
256,000,000.00 |
| Bonds Payable |
728,229,706.23 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
107,497.59 |
| Deferred Income Tax Liabilities |
23,804,029.81 |
| Other Non-Current Liabilities |
20,329,553.42 |
| Sub-Total of Non-Current Liabilities |
1,065,669,502.22 |
| Total Liabilities |
2,720,206,283.85 |
| Paid-In Capital(Or Share Stock) |
904,322,938.00 |
| Capital Surplus |
748,117,729.18 |
| Surplus Reserve |
104,386,992.88 |
| LESS:Treasury Stock |
82,517,230.96 |
| Undistributed Profits |
1,347,298,690.69 |
| Minority Stockholder's Interest |
119,079,104.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,154,709,852.54 |
| Owner's Equity（Stockholder's Equity） |
3,273,788,956.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,993,995,240.46 |
